Demonstrates clinically meaningful and highly significant reduction in moderate or severe COPD over 52 weeks, and significant improvements in lung function.
Network allows for quick and easy site enrollment and expert insight, feedback, and guidance in first-in-human Phase I and Phase II clinical oncology trials.
In the pursuit of operational excellence and continuous improvement, it is important to consider the role of people and culture in driving long-term success.